Clinical cancer journals

Mar 19, 2024 · Cancer Investigation is a well-established, international journal publishing research on all aspects of oncology. Disseminating research for more than four decades, the journal aims to provide researchers and clinicians with a comprehensive resource on the current state of progress in the field of oncology, as well as a broad background of reliable information necessary for effective decision ...

JMIR Cancer (JC, ISSN: 2369-1999, Impact Factor: 2.8) is a peer-reviewed journal focusing on education, innovation and technology in cancer care, ...Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.The concept of blood-based multicancer early detection (MCED) tests has generated much excitement, in part because of the potential of such tests to …JCO Clinical Cancer Informatics ( JCO CCI) is an online-only, interdisciplinary journal publishing clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images. Submit Subscribe For Authors. 472,713.Research shows colon cancer is the third most common type of cancer in America.1 Like bowel and rectal cancer, colon cancer involves the lower digestive system. This is why so many...Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals. Read more about editorial excellence ...A cancer diagnosis can leave you unable to comprehend anything else your doctor says, but it’s important to pay attention to what stage of cancer you have. Contrary to popular beli...

Our family of 50+ titles provides breadth and depth of coverage from basic to translational to clinical research, across all cancer types, with a wide variety of open access options. It’s a comprehensive portfolio of titles; in fact, between them, our oncology network journals publish 18 percent of all papers in the field. Colorectal cancer is the third most popular occurring cancer in men and the second most commonly occurring cancer in women. There were over 1.9 million new cases in 2020 [ 3 , 8 ]. Colorectal cancer is the second most common cause of death from cancer, estimated to be responsible for almost 935,000 cancer deaths [ 3 ].Pancreatic cancer is a deadly disease with complex etiology, diagnosis, and treatment. This article reviews the current knowledge and challenges of risk factors, biomarkers, imaging, and therapeutic options for pancreatic cancer, and provides insights for future research and clinical practice.Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the third most common cause of cancer‐related death in both men and women in the United States. CRC is rapidly shifting to diagnosis at a younger age and at a more advanced stage; however, a large proportion of CRC incidence and mortality is preventable …JCO Clinical Cancer Informatics. Featured Content. ORIGINAL REPORTS Jan 25, 2024. Synthetic Data Improve Survival Status Prediction Models in Early-Onset …BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.Nov 16, 2023 · N Engl J Med 2023;389:653-654. Approximately 2500 persons in the United States receive a diagnosis of isocitrate dehydrogenase (IDH)–mutated grade 2 glioma each year. 1 These patients tend to be ... Aug 12, 2021 · Treating cancer has been a highly complex process. Conventional treatment approaches, such as surgery, chemotherapy, and radiotherapy, have been in use, while significant advances are being made in recent times, including stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemodynamic therapy ...

Author(s): BioMed Central Ltd. Title Abbreviation: J Exp Clin Cancer Res Title(s): Journal of experimental & clinical cancer research : CR.Importance Cancer screening tests are promoted to save life by increasing longevity, but it is unknown whether people will live longer with commonly used cancer …Cancer Research Communications Fees. Cancer Research Communications is an online-only, exclusively open access journal. As such, unlike the other AACR journals noted above it has a flat article publication charge (APC). During the current launch phase, Cancer Research Communications has a special introductory APC of $2,550.Abstract. Prostate cancer is a common malignancy seen worldwide. The incidence has risen in recent decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing, although prostate cancer mortality rates have remained relatively static over that time period. A man’s risk of prostate …This journal is a member of and subscribes to the principles of the Committee on Publication Ethics. Explore breast cancer research in npj Breast Cancer, an open access journal with 5.9 Impact ...

What city is disney world in.

CA: A Cancer Journal for Clinicians is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer. CA: A Cancer Journal for Clinicians: Vol 74, No 2Methods. A systematic literature review identified systematic reviews, randomized controlled trials (RCTs), and nonrandomized studies on the efficacy …The International Journal of Cancer is the official journal of the Union for International Cancer Control. We have a global readership and receive over 4,000 submissions a year under a broad scope of topics relevant to experimental and clinical cancer research. We invite and encourage original Research Articles …Medicine Matters Sharing successes, challenges and daily happenings in the Department of Medicine ARTICLE: Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical...Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals. Read more about editorial excellence ...Cancer is a serious disease, and you should feel confident in your diagnosis and comfortable with your treatment plan. If you have doubts about either, talking to another doctor ca...

Top 100 in Cancer. This collection highlights our most downloaded* cancer papers published in 2021. Featuring authors from aroud the world, these papers showcase valuable research from an ...Anti‐cancer action of PBLs can also be enhanced by genetic modification. 103 Clinical trials of ACT for OC are ongoing. ACT has shown around 72% reaction rates that last for more than three years in metastatic melanoma occurring at. 83 This is a very promising outcome that can be translated into OC therapy by optimizing the conditions …Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials.Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy …Scientists are still optimistic about using Crispr medicinally, despite two troubling papers published this week in a leading scientific journal. The biotech industry is obsessed w...Clinical Cancer Bulletin is an open access journal covering issues relevant to clinical cancer specialists worldwide. Strives to report original, innovative, high …BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.Colorectal cancer (CRC) is the third most common diagnosis and second deadliest malignancy for both sexes combined. CRC has both strong environmental associations and genetic risk factors. The incidence of new cases and mortality has been steadily declining for the past years, except for younger adults (younger than 50 years), …Basic & Clinical Cancer Research is a peer-reviewed, open-access journal that aims to publish the highest quality articles on all aspects of cancer research, including research findings of pathophysiology, prevention, diagnosis and treatment of cancers, and technical evaluations and serves as a discussion forum for cancer scientists. Dimensions.The articles published in The New England Journal of Medicine (NEJM), The Lancet, JAMA, BMJ, and some other journals in the oncology field, as well as the abstracts reported in the conferences of the American Society of Clinical Oncology (ASCO), the World Conference on Lung Cancer (WCLC), and the European Society for …Overview. The NCCN Guidelines for Head and Neck Cancers address tumors arising in the lip, oral cavity, pharynx, larynx, and paranasal sinuses; occult primary cancer, salivary gland cancer, and mucosal melanoma are also addressed. 1,2 In 2020, it is estimated that about 65,630 new cases of oral cavity, pharyngeal, and …Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, …

The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, …

Research Articles - Clinical Trials: Immunotherapy. Research Briefs - Precision Medicine and Therapeutics. Research Articles - Precision Medicine and Imaging. Research Articles - Translational Cancer Mechanisms and Therapy. Research articles should adhere closely to the following parameters: 120–150-word statement of translational relevance ... The more granular understanding of cancer’s molecular drivers and tumor-cell-intrinsic or extrinsic vulnerabilities, and the addition of next-generation sequencing testing to clinical practice ...Worldwide, prostate cancer is the most commonly diagnosed male malignancy and the fifth leading cause of cancer death in men.[1][2] This amounted to 1,414,249 newly diagnosed cases and 375,000 deaths worldwide yearly from this disease in 2020.[1][2][3][4][5] Globally, prostate cancer is the most commonly diagnosed …Current Issue: Number 2 / April 2024. Explore topics including: The effect of a 48-hour window to schedule genetic counseling after diagnosis. Implications for the care of patients receiving antibody–drug conjugates. Malnutrition risk factors for patients with head and neck cancer. Go to current issue.As per prior literature investigating the impact of obesity on cancer treatment outcomes and survival [5, 7], the underweight subgroup (4% of total … Cancer Research Communications Fees. Cancer Research Communications is an online-only, exclusively open access journal. As such, unlike the other AACR journals noted above it has a flat article publication charge (APC). During the current launch phase, Cancer Research Communications has a special introductory APC of $2,550. Cancer Reports is an international, open access oncology journal publishing basic, translational, clinical and interdisciplinary research in cancer biology, diagnosis, treatment, outcome, supportive care, epidemiology and health disparities. We encourage data-driven, scientifically valid findings, including incremental discoveries, pilot ... Cancer articles that publish Open Access are published under the terms of the Creative Commons Attribution License. The CC BY license permits commercial and non-commercial re-use of an open access article as long as the author is properly attributed. To find out what licenses the journal offers, please consult the Author Compliance Tool.JNCI Cancer Spectrum is a peer-reviewed, open-access journal. It publishes manuscripts that describe new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research.In The Lancet Oncology, Joseph C Del Paggio and colleagues1 examine expenditures for the ten drugs with the highest expenditure between 2012 and …

Ea mobile.

Marvel shield tv series.

Background Curcumin is herbal compound that has been shown to have anti-cancer effects in pre-clinical and clinical studies. The anti-cancer effects of curcumin include inhibiting the carcinogenesis, inhibiting angiogenesis, and inhibiting tumour growth. This study aims to determine the Clinical effects of …Clinical Cancer Bulletin is an open access journal covering issues relevant to clinical cancer specialists worldwide. Strives to report original, innovative, high …Clinical Cancer Bulletin (CCB) is a strict, international, peer-reviewed, open access journal covering international issues relevant to clinical cancer specialists worldwide. The journal welcomes the submission of manuscripts related to clinical oncology, translational cancer research, precision oncology, and cancer prevention research.Closed. Several challenges and controversies exist in the domain of clinical cancer treatment. These include therapeutic modalities to achieve better therapeutic effects in tumor treatment; the efficacy of immunotherapy based on immune checkpoint inhibitors (e.g., PD1 inhibitors) and novel Chimeric antigen …Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI.The Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA), Biomedical Research Centre (CIBM), British Neuro-Oncology Society (BNOS) and Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) are …MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness. Margherita Puppo. , Manoj Kumar Valluru. & Philippe Clézardin.Cancer articles that publish Open Access are published under the terms of the Creative Commons Attribution License. The CC BY license permits commercial and non-commercial re-use of an open access article as long as the author is properly attributed. To find out what licenses the journal offers, please consult the Author Compliance Tool.Several clinical trials have been carried out using p53 vaccines. In a clinical trial by Kuball et al, six patients with advanced-stage cancer were given vaccine containing a recombinant replication-defective adenoviral vector with human wild-type p53. When followed up at 3 months post immunisation, four out of the six patients had stable …Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines. ….

Explore the latest in cancer science including checkpoint inhibitors, DCIS, breast prostate and lung cancer treatment, aspirin prevention, biomarkers, and more. [Skip to Navigation] ... Resource Center Best of the JAMA Network Caring for the Critically Ill Patient Clinical Crosswords from JAMA Coronavirus Resource Center Evidence-Based …Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and …Research Articles. Original studies offering broad impact across the fields of basic, preclinical, clinical, prevention, and epidemiologic cancer research. The reports should be well-documented, novel, and significant to the field as a whole. 250-word abstract. 32-word statement of significance. 5,000 words of text.Research shows colon cancer is the third most common type of cancer in America.1 Like bowel and rectal cancer, colon cancer involves the lower digestive system. This is why so many... Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI.The Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA), Biomedical Research Centre (CIBM), British Neuro-Oncology Society (BNOS) and Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) are affiliated with Cancers and their members receive a discount on ... Clinical Cancer Bulletin is an open access journal covering issues relevant to clinical cancer specialists worldwide. Strives to report original, innovative, high quality and timely contents in clinical oncology. Covers medical oncology, surgical oncology, radiation oncology, cancer immunotherapy, targeting therapy, multidisciplinary cancer ... Prostate cancer testing is heavily reliant on measuring prostate specific antigen (PSA) levels, which can give notoriously high false-positive results. But why is this - and how ca...Find research articles on lung cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies. ... Osimertinib (Tagrisso) improves survival in people with non-small cell lung cancer with EGFR mutations, updated clinical trial results show. People treated with osimertinib lived longer than those treated ... Clinical cancer journals, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]